|
ATL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.11459996577202E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.66340000346588E-08 |
| Normal-vs-Stage2 |
1.816640E-03 |
| Normal-vs-Stage3 |
2.63170000236457E-08 |
| Normal-vs-Stage4 |
1.09619999966171E-07 |
| Stage1-vs-Stage2 |
3.242200E-01 |
| Stage1-vs-Stage3 |
3.500800E-01 |
| Stage1-vs-Stage4 |
2.248400E-01 |
| Stage2-vs-Stage3 |
1.275550E-01 |
| Stage2-vs-Stage4 |
8.617800E-02 |
| Stage3-vs-Stage4 |
6.306400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50169999768579E-08 |
| Normal-vs-AfricanAmerican |
8.20230000000421E-05 |
| Normal-vs-Asian |
4.34669999993531E-07 |
| Caucasian-vs-AfricanAmerican |
7.637800E-01 |
| Caucasian-vs-Asian |
4.596600E-01 |
| AfricanAmerican-vs-Asian |
7.984000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.96010002567948E-09 |
| Normal-vs-Female |
6.15009999593852E-08 |
| Male-vs-Female |
1.026770E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.93240000004413E-06 |
| Normal-vs-Age(41-60Yrs) |
9.16330000766408E-09 |
| Normal-vs-Age(61-80Yrs) |
2.24600000042763E-07 |
| Normal-vs-Age(81-100Yrs) |
1.378530E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.384970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.033000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.646800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.219800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.118200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.529800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.060800E-01 |
| Classical-VS-Follicular |
9.544600E-01 |
| Classical-VS-Other |
1.516320E-03 |
| Classical-VS-Normal |
5.81150000344977E-08 |
| Tall-VS-Follicular |
2.646600E-01 |
| Tall-VS-Other |
4.447600E-02 |
| Tall-VS-Normal |
1.90030000002395E-06 |
| Follicular-VS-Other |
1.560880E-03 |
| Follicular-VS-Normal |
2.16739999999715E-05 |
| Other-VS-Normal |
5.75390000090437E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18380000024843E-07 |
| Normal-vs-N1 |
7.57789997418712E-09 |
| N0-vs-N1 |
8.181900E-02 |
|
|
